Sandoz launches generic Diovan tabs

PRINCETON, N.J. — Sandoz on Monday announced the launch of valsartan tablets, an authorized generic version of Diovan tablets. The drug is used for the treatment of high blood pressure. Sandoz previously launched an authorized generic version of Diovan HCT (valsartan and hydrochlorothiazide) in 2012. Both drugs are marketed in by Novartis Pharmaceuticals Corp.

“We are pleased to offer authorized generic versions of these leading anti-hypertensive medicines, which together represent the number one prescribed branded ARB medicine in the US,” said Peter Goldschmidt, president of Sandoz. “This important partnership with our colleagues at NPC is further evidence of the key role played by Sandoz and Novartis in increasing patient access to high-quality healthcare.”

Net sales for Diovan and Diovan HCT in 2013 were approximately $1.7 billion. Sandoz will market generic Diovan in 40-mg, 80-mg, 160-mg and 320-mg dosage strengths.